Discounted Cash Flow Rating

Return on Equity Rating

Debt to Equity Rating

Price to Earnings Rating

Analyst Rating

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Sell

C

Indivior PLC Ordinary Shares (INDV)

http://www.indivior.com

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/24/2014

Market Cap

1,694,453,867

Shares Outstanding

136,290,000

Weighted SO

136,076,096

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

Beta

0.1750

Last Div

0.0000

Range

9.14-23.89

Chg

0.4350

Avg Vol

480362

Mkt Cap

1694453867

Exch

NASDAQ

Country

US

Phone

804 379 1090

DCF Diff

16.3359

DCF

-3.8559

Div Yield

0.0000

P/S

1.4809

EV Multiple

45.2895

P/FV

-14.1011

Div Yield %

0.0000

P/E

-12.5169

PEG

-1.3298

Payout

0.0000

Current Ratio

0.8538

Quick Ratio

0.6848

Cash Ratio

0.2984

DSO

89.6538

DIO

227.3888

Op Cycle

317.0425

DPO

61.1689

CCC

255.8736

Gross Margin

0.7601

Op Margin

-0.0114

Pretax Margin

-0.1612

Net Margin

-0.1192

Eff Tax Rate

0.2672

ROA

-0.0888

ROE

8.1266

ROCE

-0.0249

NI/EBT

0.7393

EBT/EBIT

14.1396

EBIT/Rev

-0.0114

Debt Ratio

0.1616

D/E

-2.0496

LT Debt/Cap

2.0614

Total Debt/Cap

1.9528

Int Coverage

-0.3724

CF/Debt

-0.9420

Equity Multi

-12.6860

Rec Turnover

4.0712

Pay Turnover

5.9671

Inv Turnover

1.6052

FA Turnover

10.6917

Asset Turnover

0.7453

OCF/Share

-1.7327

FCF/Share

-2.1172

Cash/Share

2.8110

OCF/Sales

-0.2042

FCF/OCF

1.2219

CF Coverage

-0.9420

ST Coverage

-17.9707

CapEx Coverage

-4.5068

Div&CapEx Cov

-4.5068

P/BV

-14.1011

P/B

-14.1011

P/S

1.4809

P/E

-12.5169

P/FCF

-5.9350

P/OCF

-7.3035

P/CF

-7.3035

PEG

-1.3298

P/S

1.4809

EV Multiple

45.2895

P/FV

-14.1011

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jun 05, 05:00 Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference GlobeNewswire Inc. Sep 30, 23:29 Indivior PLC Investors: Please contact the Portnoy Law Firm to recover your losses. October 1, 2024 Deadline to file Lead Plaintiff Motion GlobeNewswire Inc. Sep 16, 22:24 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Indivior PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action – INDV GlobeNewswire Inc. Sep 14, 00:09 INVESTOR ALERT: DiCello Levitt LLP Shareholder Class Action Lawsuit Filed Against Indivior PLC (NASDAQ: INDV); Investors with Losses Encouraged to Discuss Their Options with Counsel GlobeNewswire Inc. Sep 13, 21:54 ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Indivior PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action – INDV GlobeNewswire Inc. Sep 11, 23:32 DEADLINE ALERT for ABR, FIVE, INDV, DXC: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire Inc. Sep 05, 22:30 Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Indivior PLC (INDV) GlobeNewswire Inc. Sep 02, 01:26 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Indivior PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action – INDV GlobeNewswire Inc. Aug 23, 22:19 Pending Lead Plaintiff Deadline in the INDV Class Action: Robbins LLP Reminds Stockholders with Large Losses of Indivior PLC to Seek Counsel GlobeNewswire Inc. Aug 22, 22:40 ROSEN, LEADING INVESTOR COUNSEL, Encourages Indivior PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action – INDV GlobeNewswire Inc. Aug 21, 22:30 Strategic Opportunities in Thin Film Drug Manufacturing Market to Expand to USD 16.5 Billion by 2034, Driving Industry Growth | Transparency Market Research Inc. GlobeNewswire Inc. Aug 19, 03:55 Shareholder Rights Law Firm Robbins LLP Urges INDV Stockholders to Contact the Firm for Information About the Indivior PLC Class Action GlobeNewswire Inc. Aug 13, 02:46 INDV CLASS ACTION ALERT: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Indivior PLC Class Action GlobeNewswire Inc. Aug 03, 20:40 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Indivior PLC of Class Action Lawsuit and Upcoming Deadlines – INDV GlobeNewswire Inc. Jul 15, 05:00 Addex Presents Positive Results from GABAB PAM Cough - GlobeNewswire Benzinga Dec 15, 12:46 Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Revenue Product Segmentation